| TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea GG Kovacs, JR Murrell, S Horvath, L Haraszti, K Majtenyi, MJ Molnar, ... Movement Disorders 24 (12), 1842-1847, 2009 | 246 | 2009 |
| Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles MJ Molnar, R Gilbert, Y Lu, AB Liu, A Guo, N Larochelle, K Orlopp, ... Molecular Therapy 10 (3), 447-455, 2004 | 186 | 2004 |
| A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions H Tyynismaa, E Ylikallio, M Patel, MJ Molnar, RG Haller, A Suomalainen The American Journal of Human Genetics 85 (2), 290-295, 2009 | 149 | 2009 |
| Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial J Diaz-Manera, PS Kishnani, H Kushlaf, S Ladha, T Mozaffar, V Straub, ... The Lancet Neurology 20 (12), 1012-1026, 2021 | 137 | 2021 |
| Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double … B Schoser, M Roberts, BJ Byrne, S Sitaraman, H Jiang, P Laforêt, ... The Lancet Neurology 20 (12), 1027-1037, 2021 | 101 | 2021 |
| Cerebral blood flow and glucose metabolism in mitochondrial disorders MJ Molnár, A Valikovics, S Molnár, L Trón, P Diószeghy, F Mechler, ... Neurology 55 (4), 544-548, 2000 | 95 | 2000 |
| Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases B Zurek, K Ellwanger, LELM Vissers, R Schüle, M Synofzik, A Töpf, ... European Journal of Human Genetics 29 (9), 1325-1331, 2021 | 91 | 2021 |
| Mitochondrial diseases MJ Molnar, GG Kovacs Handbook of clinical neurology 145, 147-155, 2018 | 91 | 2018 |
| Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries T Zelei, MJ Molnár, M Szegedi, Z Kaló Orphanet journal of rare diseases 11, 1-11, 2016 | 81 | 2016 |
| Psychiatric symptoms of patients with primary mitochondrial DNA disorders G Inczedy-Farkas, V Remenyi, A Gal, Z Varga, P Balla, ... Behavioral and Brain Functions 8, 1-9, 2012 | 74 | 2012 |
| MAPT S305I mutation: implications for argyrophilic grain disease GG Kovacs, A Pittman, T Revesz, C Luk, A Lees, E Kiss, P Tariska, ... Acta neuropathologica 116, 103-118, 2008 | 73 | 2008 |
| MSTO 1 is a cytoplasmic pro‐mitochondrial fusion protein A Gal, P Balicza, D Weaver, S Naghdi, SK Joseph, P Várnai, T Gyuris, ... EMBO molecular medicine 9 (7), 967-984, 2017 | 63 | 2017 |
| Mitochondrial dysfunction and autism: comprehensive genetic analyses of children with autism and mtDNA deletion NÁ Varga, K Pentelényi, P Balicza, A Gézsi, V Reményi, V Hársfalvi, ... Behavioral and Brain Functions 14, 1-14, 2018 | 60 | 2018 |
| Efficacy of nusinersen in type 1, 2 and 3 spinal muscular atrophy: real world data from Hungarian patients L Szabó, A Gergely, R Jakus, A Fogarasi, Z Grosz, MJ Molnár, I Andor, ... European Journal of Paediatric Neurology 27, 37-42, 2020 | 58 | 2020 |
| Rare variants in β-Amyloid precursor protein (APP) and Parkinson’s disease EC Schulte, A Fukumori, B Mollenhauer, H Hor, T Arzberger, R Perneczky, ... European Journal of Human Genetics 23 (10), 1328-1333, 2015 | 55 | 2015 |
| Peripheral nerve and skeletal muscle involvement in CADASIL JM Schröder, S Züchner, M Dichgans, Z Nagy, MJ Molnar Acta neuropathologica 110, 587-599, 2005 | 54 | 2005 |
| How bioinformatics influences health informatics: usage of biomolecular sequences, expression profiles and automated microscopic image analyses for clinical needs and public health V Kuznetsov, HK Lee, S Maurer-Stroh, MJ Molnár, S Pongor, ... Health Information Science and Systems 1, 1-18, 2013 | 50 | 2013 |
| Structural and molecular basis of skeletal muscle diseases G Karpati, M Molnar ISN Neuropath Press, 2002 | 49 | 2002 |
| The European reference network for rare neurological diseases C Reinhard, AC Bachoud-Lévi, T Bäumer, E Bertini, A Brunelle, AI Buizer, ... Frontiers in neurology 11, 616569, 2021 | 47 | 2021 |
| The European challenges of funding orphan medicinal products M Szegedi, T Zelei, F Arickx, A Bucsics, E Cohn-Zanchetta, J Fürst, ... Orphanet journal of rare diseases 13, 1-8, 2018 | 46 | 2018 |
Balicza PéterSemmelweis University, Institute of Genomic Medicine and Rare DisordersVerified email at med.semmelweis-univ.hu